441P - OT-1096: A first-in-class immunoactivating small molecule that targets the thioredoxin reductase/thioredoxin axis causes strong tumor growth inhibition by downregulating intratumoral tregs in a humanized TNBC-PDX model

Autor: Orwar, O., Lowstedt, I., Andersson, K., Gannedahl, G., Willman, G., Davidsson, M., Stafford, W., Trkulja, C.
Zdroj: In Annals of Oncology October 2018 29 Supplement 8
Databáze: ScienceDirect